Suppliers / Pharmascience

Pharmascience

Brazil Updated 9 July 2026

Pharmascience is a finished-dose manufacturer based in Brazil. It appears in 1,883 regulatory filings across 13 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada, ANVISA (Brazil) and DAV (Vietnam). Its GMP standing is certified by ANVISA (Brazil), MFDS (Korea) and EMA, among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 13 February 2024 as VAI.

0
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
1,883
filings across 13 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
5 of 5 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 13 February 2024 VAI US FDA
  • 18 June 2019 VAI US FDA
  • 5 February 2018 NAI US FDA
  • 17 November 2014 NAI US FDA
  • 13 July 2010 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Montreal, United Arab Emirates Not on file
BETIM, Brazil Not on file
Canada, Canada 3002806578
Nicosia, Cyprus Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
Health Canada 1,630 None
ANVISA (Brazil) 173 3
DAV (Vietnam) 51 None
MINSA (CR) 8 None
INFARMED (PT) 5 None
US FDA 4 1
MFDS (Korea) None 2
EMA None 1

Comparing suppliers?

Choose your molecules and target markets. Pharmascience comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 13 February 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates